TTK Healthcare Reports FY26 Revenue Growth Amid Profit Decline

TTK Healthcare posted ₹857.28 crore in revenue for FY 2026, a 6.96% increase year-on-year.
Net profit after tax, however, saw a 19.57% decline, settling at ₹65.68 crore for the fiscal year.

Reader Takeaway: Revenue grew, but net profit dropped due to higher costs and segment losses.

What just happened

TTK Healthcare Limited announced its audited financial results for the financial year ended March 31, 2026. The company reported a revenue of ₹857.28 crore, an increase from ₹801.49 crore in the previous fiscal year. However, its net profit after tax declined by 19.57% to ₹65.68 crore, down from ₹81.66 crore in FY 2025. The company also noted an exceptional charge of ₹4.07 crore in FY 2026 related to labor code impacts and GST refunds.

Why this matters

The revenue growth indicates sustained demand for the company's products and services. However, the significant drop in net profit, despite revenue increase, raises concerns about cost management and operational efficiencies. Investors will be keen to understand the factors contributing to this profitability squeeze, especially the impact of the Protective Devices segment's loss.

The backstory

In FY 2025, TTK Healthcare had reported a net profit of ₹81.66 crore on revenues of ₹801.49 crore. The company operates across various segments including Animal Welfare, Consumer Products, Medical Devices, Protective Devices, and Foods. The reappointment of Mr. T T Raghunathan as Executive Chairman for another five years ensures leadership continuity.

What changes now

Shareholders can look forward to a recommended dividend of ₹10 per equity share (100% payout), subject to approval. The reappointment of the Executive Chairman provides stability. The focus will now shift to the company's ability to improve profitability in the upcoming financial year, particularly by addressing the issues in the Protective Devices segment and managing the costs associated with new labor codes.

Risks to watch

The primary risk highlighted is the decline in net profit, which could indicate rising operational costs or competitive pressures impacting margins. The loss in the Protective Devices segment suggests potential operational challenges. Additionally, the company's management of potential future impacts from new labor codes on employee benefit liabilities will be crucial.

Peer comparison

(No peer comparison data was provided in the filing.)

Context metrics (time-bound)

• Revenue from operations grew by 6.96% year-on-year for FY 2026.
• Net profit after tax declined by 19.57% year-on-year for FY 2026.
• The Protective Devices segment reported a loss of ₹-10.54 crore in FY 2026.

What to track next

Investors should monitor the company's performance in the next financial year, focusing on profit margins, the turnaround of the Protective Devices segment, and any updates on managing the impact of labor code-related expenses. The dividend payout will also remain a key point for income-seeking investors.